FOXO3 and metabolic disease: Importantly, interactions between SIRT1, peroxisome proliferator-activated receptor gamma coactivator 1 (PPARGC1A), and FOXO1/FOXO3 indicate a strong mitochondrial and antioxidant component, aligning with their roles in metabolic disease and aging.